Get notified when MLYS files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsMineralys Therapeutics reports Q4 and full-year 2025 financial results
Filed March 12, 2026 · Period ending March 12, 2026 · ~1 min read
Key Changes
-
medium
Company announced fourth quarter and full fiscal year 2025 financial results along with a corporate update via press release on March 12, 2026.
Item 2.02 verify on EDGAR → -
low
The 8-K filing references the press release but does not include actual financial figures or performance metrics in the filing body itself.
8-K body view on EDGAR → -
low
Information is furnished under Item 2.02, meaning it is not formally 'filed' and carries limited legal liability compared to standard SEC filings.
Item 2.02 disclaimer verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade MLYS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify